✦ LIBER ✦

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

✍ Scribed by Matthias Kroiss; Marcus Quinkler; Werner K. Lutz; Bruno Allolio; Martin Fassnacht

Book ID: 108705062
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 93 KB
Volume: 75
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2011.04214.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychotropic drug metabolism in the canc

Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions

✍ Glenn R. Kalash 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

An overview of drug metabolism, with particular focus on the cytochrome p450 system, is provided in this review. To date, there has been a growing body of literature concerning the cytochrome p450 enzyme, drug -drug interactions and the role of psychotropic medications when co-administered with medi

In vitro metabolism of the opioid tilidi

In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6

✍ Johanna Weiss; Evelyn Sawa; Klaus-Dieter Riedel; Walter Emil Haefeli; Gerd Mikus 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part three: individual patient, complication algorithm and quality management¶

✍ B. Stinner; A. Bauhofer; W. Lorenz; M. Rothmund; U. Plaul; A. Torossian; I. Celi 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 218 KB